Asia-Pacific Journal of Clinical Oncology

Papers
(The TQCC of Asia-Pacific Journal of Clinical Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
“Artificial Intelligence in NAFLD Diagnosis: A New Frontier in Managing Metastatic Prostate Cancer Risk”90
34
Systematic Literature Review on the Burden of Human Papillomavirus Infection and Related Diseases in India24
18
Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies16
15
Real‐world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study15
The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience13
Incidence and risk factors for neoplasia in inflammatory bowel disease12
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival12
Issue Information11
Immune Checkpoint Activity and Prognostic Roles of TNFRSF8, CD160, and TNFSF9 in Primary and Brain Metastatic NSCLC11
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review11
Optimizing Digital Mental Health Interventions for Breast Cancer Survivors: Insights and Future Directions11
Organising Committee10
Issue Information10
Analysis of Clinical Factors Impacting Imatinib Trough Concentrations in Chinese Patients With Gastrointestinal Stromal Tumors: A Real‐World Study9
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy9
9
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?9
Berberine and Lung Cancer: From Pure Form to Its Nanoformulations9
In Need of Rescue: Modernizing and Redefining Treatment Intent in Oncology8
Integrated Strategies for Nursing and Rehabilitation in Lung Cancer Patients8
Real‐World Outcomes of Patients Treated With Neoadjuvant Imatinib for Locally Advanced, Recurrent and Limited Metastatic Gastrointestinal Stromal Tumour in an Australian Cancer Training Network8
8
Issue Information8
Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study8
Glucose to lymphocyte ratio predicts prognoses in patients with colorectal cancer8
Impact of age on outcomes in young women with breast cancer8
Real‐World Experience Using Brigimadlin (MDM2 Inhibitor) in an Australian Sarcoma Specialist Center Compared to Pivotal Clinical Trial Results8
Unveiling the Characteristics and Survival Outcomes of Double Primary Cancers in Taiwan: A Nationwide Population‐based Comparison Cohort Study8
Participation in oral health screening among cancer survivors8
Breast Cancer Awareness and the Practice of Self Breast Examination Among Undergraduate Students in Karachi, Pakistan7
Multi‐omic analysis of dysregulated pathways in triple negative breast cancer7
Effectiveness and Toxicity of Anticancer Agents in Older Australian Patients: A Retrospective Analysis7
Issue Information7
Functional results and feasibility of a teleprehabilitation program in patients who are candidates for elective colorectal cancer surgery during the COVID‐19 pandemic7
National Speakers6
6
TNM classification of malignant tumors: Eighth edition for retroperitoneal liposarcoma. Ways to improve6
Poster Abstracts6
COSA Committees6
Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region6
International Speakers6
Demographic and clinical profile of 1106 adult soft tissue sarcoma patients: A single institutional prospective database experience from India6
Telehealth adoption in cancer clinical trials: An Australian perspective6
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries6
6
Author Index6
6
Author Listing6
Hematological Markers Predict Immune‐Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Pembrolizumab6
Established Prognostic Scores Predict Screen Failure But Not Post‐Enrollment Outcomes in Phase 1 Oncology Trials: A Single Centre Retrospective Audit6
Epstein‐Barr Virus‐positive NK/T‐cell Malignancies in Poland: Distinctive Features, Therapeutic Strategies, and Survival Insights—The Real‐world Retrospective Report of the Polish Lymphoma Research Gr6
6
Pan‐Cancer Analysis and Functional Characterization Identify SLC15A4 as a Novel Prognostic Biomarker and Therapeutic Target6
Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer5
2025 MOGA Annual Scientific Meeting PROGRAM and ABSTRACTS5
Comparative Real‐World Safety Profiles of Fibroblast Growth Factor Receptor Inhibitors: A Pharmacovigilance Study5
Risk classification system using the detailed positive surgical margin status for predicting biochemical recurrence after robot‐assisted radical prostatectomy5
Real‐world tolerance and outcomes of oxaliplatin‐based adjuvant chemotherapy for stage III colon cancer—Does dose intensity matter?5
5
Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy5
Issue Information5
Abstracts5
Sponsor & Exhibitor Profiles5
Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously T5
Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications5
Convenors' Welcome5
Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?5
What affects the public healthcare costs of breast cancer in New Zealand?5
The MASCC COG‐IMPACT: The COSA Endorsement of a MASCC Developed Unmet Needs Assessment Tool for Cancer‐Related Cognitive Impairment Impact4
Issue Information4
The benefits of an offline to online cognitive behavioral stress management regarding anxiety, depression, spiritual well‐being, and quality of life in postoperative intrahepatic cholangiocarcinoma pa4
Poster Abstracts4
The clinical utility of autologous tumor lysate‐loaded dendritic cell vaccination for patients with glioma: A systematic review and meta‐analysis4
Impact of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinoma4
Evaluation of a Modified Proprietary Electronic Patient Reported Outcome Measures Tool for Monitoring Toxicities Associated With Systemic Chemotherapy4
Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics4
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–20224
Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy4
Acute Toxicity With Trastuzumab Emtansine and Concurrent Radiotherapy: Non‐Consecutive Case Series4
Larotrectinib in Adjuvant and First‐Line Treatment for Metastatic NTRK Fusion Colon Cancer4
COSA President's Welcome4
Quercetin as a Therapeutic Agent for Oral Cancer: Current Evidence and Future Directions4
Evaluation of the anticarcinogenic effects of Rutin on brain tissue in mice with Ehrlich ascites carcinoma by micro‐computed tomography and histological methods4
Prognostic Value of CD133 and SOX2 Expression After Neoadjuvant Chemotherapy in Patients With Locally Advanced Gastric Cancer4
4
A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis4
Implementing a group‐based online mental well‐being program for women living with and beyond breast cancer – A mixed methods study4
A multidimensional assessment of payback: Evaluating the impact of Breast Cancer Trials4
Exploring the molecular mechanisms network of breast cancer by multi‐omics analysis4
CD151 and prostate cancer progression: A review of current literature4
Cancer Clinical Trial Participation Amongst Culturally and Linguistically Diverse Patients in Australia4
Biomarker‐Guided Inflammatory Control and Multidimensional Recovery After Abdominoperineal Resection: A Prospective Cohort Study4
Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early‐onset colorectal cancer: A narrative review4
Issue Information3
Prevalence and risk factors of chemotherapy‐induced oral mucositis among adult cancer patients at the cancer unit of Mbarara Regional Referral Hospital3
Trainee Oral Presentation Abstracts3
Overdiagnosis and overtreatment of ground‐glass nodule‐like lung cancer3
A novel exosome‐related prognostic risk model for thyroid cancer3
eviQ Cancer Treatments Online: Providing evidence‐based information to improve cancer patient outcomes3
3
Comparison of direct medical care costs between patients receiving care in a designated palliative care unit and the usual care units3
Perspectives of the Use of Neoadjuvant Therapy in the Management of Locally Advanced and Locally Recurrent Colon Cancer: A Bi‐National Survey of Colorectal Surgeons3
The Increasing Importance of Breast Cancer in the United Arab Emirates3
Author List3
Highlighted Lectures and Awards 20223
Perceived importance of emotional support provided by health care professionals and social networks: Should we broaden our focus for the delivery of supportive care?3
Advancements in Cancer Research: Exploring the Role of 3D Bioprinting3
Clinical Impact of Upfront Dose Reduction of the First Cycle of First‐Line Treatments on Safety and Survival in Elderly Patients With Non‐Small Cell Lung Cancer3
The burden of symptoms and quality of life of filipino patients with myeloproliferative neoplasm: A multicenter cross‐sectional survey3
3
Early Lung Cancer Patient Journey in Singapore: Challenges and Recommendations3
Prolonged Survival in Anaplastic Thyroid Cancer: Insights From Multi‐Modal Treatment3
Issue Information3
Author Index3
3
Young Oncologist Oral Presentation Abstracts3
Does Limited‐Margin Radiotherapy Change the Recurrence Pattern and Survival of Patients With IDH‐Wild–Type Glioblastoma? Analysis and Validation of a Different Approach3
Methyltransferase‐Like 3 in Gastric Cancer: Advances in Understanding Its Intricate Roles and Therapeutic Implications3
Selective internal radiation therapy with yttrium‐90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma3
Poster Listing3
Palbociclib in the Treatment of HR+/ HER2‐ Advanced or Metastatic Breast Cancer in Australia: A Real‐World Retrospective Analysis3
Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series3
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database3
E74‐like factor 4 promotes the proliferation, invasion, and migration of colorectal cancer cells via long non‐coding RNA integrin subunit beta 8 antisense RNA 1‐mediated histone H3 lysine 27 trimethyl2
The Significance of Circulating Basophils as Predictors of Tumor Aggressiveness in Clear‐Cell Renal Cell Carcinoma2
Purified Cucurbitacin D Leads to Alterations of Apoptotic and Autophagic Genes Expression in MDA‐MB‐468 and MCF‐7 Human Breast Cancer Cells2
Convenor Welcome2
Exercise capacity prior to major cancer surgery: A cross‐sectional observational study of the validity of the 6‐minute walk and 30‐second sit‐to‐stand tests2
Thoracic Cancer Exercise Services in Australia: A Point‐Prevalence Survey2
Long‐term Longitudinal Observation of Lenvatinib‐associated Adverse Events in Patients With Unresectable Radioiodine‐refractory Differentiated Thyroid Cancer2
Presenters and Chairs2
2
Oncological outcomes for encapsulated papillary carcinoma of the breast: Multicentric study of Turkish Society for Radiation Oncology breast cancer study group (TROD 06–014 study)2
Lung V5 and Planning Target Volume/Lung Volume Ratio as Independent Risk Factors for ≥Grade 2 Radiation Pneumonitis after Moderately Hypofractionated Radiotherapy: A Retrospective Study2
Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer Trials2
Breast cancer characteristics and pathological prognostic determinants in indigenous Australians: Retrospective cohort study in the Northern Territory2
Non‐alcoholic fatty liver disease increases the risk of biochemical recurrence in high‐grade metastatic prostate cancer patients2
Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma2
Acknowledgements2
Clinical breast examination: A screening tool for lower‐ and middle‐income countries2
Metastatic Lobular Breast Cancer: Outcomes of Patients Treated at a Single Tertiary Institution2
Clinical Oncology Society of Australia Position Statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings2
Treatment Efficacy, Chemoradiotherapy Benefits, and Survival Disparities by Histology in Primary Mediastinal Germ Cell Tumors: 15‐Year Results of a Single‐Center Cohort Study2
Inflammation‐Based Prognostication in Extensive‐Stage Small Cell Lung Cancer in the First‐Line Setting: The Advanced Lung Inflammation Index and the Others2
Real‐world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study2
BRCA Mutation Testing in Men With Metastatic Castration‐Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice2
Highlighted Lectures and Awards 20242
Consumers’ experiences, preferences, and perceptions of effectiveness in using telehealth for cancer care in Australia2
Pattern of Metastasis as a Risk Factor for Brain Metastasis in Patients With Breast Cancer: A Time‐Dependent Cox Regression2
2025 AGITG ASM Abstract Book2
Outcomes and prognostic predictors of Lu‐177 PSMA radioligand therapy in metastatic castration‐resistant prostate cancer (Asian Population Study)2
Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India2
Change in the Neutrophil–Lymphocyte Ratio and Recurrence in Operated Bladder Cancer2
Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative2
Comparison of antibody response to coronavirus disease 2019 vaccination between patients with solid or hematologic cancer patients undergoing chemotherapy2
Papillary Tumors of the Pineal Region (PTPR) in Pediatric Population: A Case Report and Literature Review2
Clinical features of gestational choriocarcinoma: A retrospective bicentric study2
Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia2
Early phase oncology clinical trials in Malaysia: current status and future perspectives2
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapy2
Program in Detail2
Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study2
Quality Survivorship Care for People Affected by Advanced or Metastatic Cancer: A Clinical Oncology Society of Australia Endorsement of the Joint Multinational Association of Supportive Care in Cancer2
Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population2
Update of the Australian Guideline for the Management of Cancer Pain in Adults2
Rethinking the Metrics: A Critical Lens on Neoadjuvant Therapy Implementation in Malaysia's Breast Cancer Landscape2
0.38932991027832